Using Surrogate Samples For IVD Trials: MDIC Issues A Framework
The group that helped developed a framework to incorporate patient preference data into regulatory device submissions has released a new document to help in vitro diagnostics sponsors tackle the problem of limited sampling by using surrogate samples. The plan has been reviewed by top FDA officials.
You may also be interested in...
The Medical Device Innovation Consortium is launching a new pilot project with FDA and the Michael J. Fox Foundation to incorporate patient preference into device trials in a ‘scientifically valid way’, according to MDIC CEO Bill Murray, who spoke to MedTech Insight from the AdvaMed 2016 conference in Minneapolis. In our video interview, Murray discusses the project's aim to adjust the statistical design of a study for Parkinson's disease based on patients' willingness to accept risks.
In an exclusive and wide-ranging interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association, said the previous four Medical Device User Fee negotiations with the FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place.
Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.